Shopping Cart
- Remove All
- Your shopping cart is currently empty
Troriluzole is an orally active glutamate modulator with anticancer activity.Troriluzole enhances the expression of excitatory amino acid transporters located in glial cells and is used in the study of spinocerebellar ataxia, Alzheimer's disease, and generalized anxiety disorder (GAD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $100 | In Stock | |
5 mg | $247 | In Stock | |
10 mg | $396 | In Stock | |
25 mg | $728 | In Stock | |
50 mg | $1,160 | In Stock | |
100 mg | $1,730 | In Stock | |
1 mL x 10 mM (in DMSO) | $272 | In Stock |
Description | Troriluzole is an orally active glutamate modulator with anticancer activity.Troriluzole enhances the expression of excitatory amino acid transporters located in glial cells and is used in the study of spinocerebellar ataxia, Alzheimer's disease, and generalized anxiety disorder (GAD). |
In vitro | Troriluzole is an EAAT2 modulator, NMDA receptor antagonist, and Nav1.5 blocker, commonly used in research on neurological disorders such as obsessive-compulsive disorder[1]. |
Alias | FC 4157, BHV-4157a, BHV-4157, BHV4157, BHV 4157 |
Molecular Weight | 419.38 |
Formula | C15H16F3N5O4S |
Cas No. | 1926203-09-9 |
Smiles | CN(CC(=O)Nc1nc2ccc(OC(F)(F)F)cc2s1)C(=O)CNC(=O)CN |
Relative Density. | 1.518 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 30 mg/mL (71.53 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.